glp-1 system From metabolism to mind: The expanding role of the receptor in neurotherapeutics Network targets skin evenness and regeneration Understanding GLP-1 receptor agonists and

AKI was identified using creatinine-based KDIGO criteria without systematic adjudication of precipitating factors

Over the five-year follow-up period, the risk of a major cardiovascular event was 4.3% for GLP-1RA users compared to 5.0% for non-users (Hazard Ratio [HR] = 0.85

7 Semaglutides role in the medical triad of diabetes, obesity, and cancer The prevalence of T2DM has increased significantly in the past decades

Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Peptide-1 Receptor Agonists

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies